Testicular cancer incidence statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of testicular cancer, 2015-2017, UK

 

Proportion of all cases

Percentage testicular cancer is of total cancer cases, 2015-2017, UK

 

Age

Peak rate of testicular cancer cases, 2015-2017, UK

 

Trend over time

Change in testicular cancer incidence rates since the early 1990s, Males, UK

 

Testicular cancer is the 18th most common cancer in males in the UK, accounting for 1% of all new cancer cases in males (2017).

In females and males combined, testicular cancer is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2017).[1-4]

Testicular cancer incidence rates (European age-standardised (AS) rates Open a glossary item) are significantly higher than the UK average in Scotland, and similar to the UK average in all other UK constituent countries.

Testicular Cancer (C62), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Males, UK, 2017

  England Scotland Wales Northern Ireland UK
Male Cases 1,854 197 95 60 2,206
Crude Rate 6.7 7.5 6.2 6.5 6.8
AS Rate 6.7 7.4 6.5 6.6 6.7
AS Rate - 95% LCL 6.4 6.4 5.2 4.9 6.5
AS Rate - 95% UCL 7.0 8.5 7.8 8.3 7.0
Persons Cases 1,854 197 95 60 2,206
Crude Rate 3.3 3.6 3.0 3.2 3.3
AS Rate 3.3 3.6 3.2 3.2 3.3
AS Rate - 95% LCL 3.2 3.1 2.6 2.4 3.2
AS Rate - 95% UCL 3.5 4.1 3.9 4.1 3.5

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item  around the AS Rate Open a glossary item
 

For testicular cancer, there are few established risk factors therefore differences between countries largely reflect differences in diagnosis and data recording.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2017, ICD-10 C62.

Last reviewed:

Testicular cancer incidence is strongly related to age, with the highest incidence rates being in the 30 to 34 age group. In the UK in 2015-2017, on average each year only 1% of new cases (1%) were in males aged 75 and over.[1-4] This is a much lower proportion of cases in older age groups compared with most cancers.

Age-specific incidence rates rise steeply from around age 10-14, peak at age 30-34 and then decline rapidly. The highest rates are in the 30 to 34 age group.

Testicular cancer (C62), Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Males, UK, 2015-2017

The age distribution of testicular cancer cases may reflect an association with pubertal hormones.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2015-2017, C62.

Last reviewed:

Testicular cancer European age-standardised (AS) incidence rates for males increased by 24% in the UK between 1993-1995 and 2015-2017.[1-4].

Over the last decade in the UK (between 2005-2007 and 2015-2017), testicular cancer AS incidence rates for males remained stable.[1-4]

Testicular Cancer (ICD-10 C62), European Age-Standardised Incidence Rates, Males, UK, 1993-2017

Testicular cancer incidence rates have varied between age groups in males in the UK since the early 1990s.[1-4] Rates in 0-24s have remained stable, in 25-49s have increased by 25%, in 50-59s have increased by 50%, in 60-69s have increased by 37%, in 70-79s have remained stable, and in 80+s have remained stable.

Testicular Cancer (ICD-10 C62), European Age-Standardised Incidence Rates, By Age, Males, UK, 1993-2017

Testicular cancer incidence trends are difficult to explain in terms of prevalence of risk factors or changes in diagnostic techniques or data recording.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1993-2017, ICD-10 C62.

Last reviewed:

The largest proportion of testicular cancer cases occur in descended testicles Open a glossary item, with a smaller proportion in undescended testicles Open a glossary item (2010-2012).[1-4] This largely reflects that undescended testicles are less common than descended testicles, and testicular cancer risk is higher in undescended testicles.

A large proportion of cases did not have further details about the affected testicle recorded in cancer registry data.[1-4]

Cases and percentages may not sum due to rounding

References

  1. Data were provided by the Office for National Statistics on request, July 2014. Similar data can be found here: http://www.ons.gov.uk/ons/rel/vsob1/cancer-statistics-registrations--england--series-mb1-/index.html.
  2. Data were provided by ISD Scotland on request, April 2014. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit on request, April 2014. Similar data can be found here: http://www.wales.nhs.uk/sites3/page.cfm?orgid=242&pid=59080.
  4. Data were provided by the Northern Ireland Cancer Registry on request, June 2014. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/CancerInformation/.

About this data

Data is for: UK, 2010-2012, ICD-10 C62

Last reviewed:

Testicular cancer incidence rates are projected to rise by 12% in the UK between 2014 and 2035, to 10 cases per 100,000 males by 2035.[1]

Testicular cancer (C62), Observed and Projected Age-Standardised Incidence Rates, by Sex, UK, 1979-2035

It is projected that 2,921 cases of testicular cancer will be diagnosed in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C62

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

Testicular cancer incidence rates (European age-standardised (AS) rates Open a glossary item) in England in males are 16% lower in the most deprived quintile compared with the least (2013-2017).[1]

It is estimated that there are around 190 more cases of testicular cancer each year in England than there would be if every deprivation quintile had the same age-specific crude incidence rates as the least deprived quintile.

Testicular Cancer (C62), Estimated Average Number of Fewer Cases per Year, by Deprivation Quintile, England, 2013-2017

Testicular Cancer (C62), European Age-Standardised Incidence Rates per 100,000 Population, by Deprivation Quintile, England, 2013-2017

References

  1. Calculated by the Cancer Intelligence Team at Cancer Research UK, April 2020. Based on method reported in National Cancer Intelligence Network Cancer by Deprivation in England Incidence, 1996-2010 Mortality, 1997-2011 . Using cancer incidence data 2013-2017 (Public Health England) and population data 2013-2017 (Office for National Statistics) by Indices of Multiple Deprivation 2015 income domain quintile, cancer type, sex, and five-year age band.

About this data

Data is for England, 2013-2017, ICD-10 C62.

Last reviewed:

Incidence rates for White males with testicular cancer is significantly higher than rates for Asian or Black males.[1]

Analysis of the Thames Cancer Registry included unknown data. For testicular cancer, 194 590 cases were identified; 33% had no known ethnicity.

Last reviewed:

An estimated 34,900 people who had been diagnosed with testicular cancer between 1991 and 2010 were alive in the UK at the end of 2010.[1]

References

  1. Macmillan Cancer Support and National Cancer Registration and Analysis Service. Cancer Prevalence UK Data Tables. London: NCRAS; 2015.

About this data

Data is for: Great Britain (1991-2010) and Northern Ireland (1993-2010), ICD-10 C62

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.